Recent Advances in Drug Discovery and Cancer Diagnoses-Reference-Cited by-同舟云学术

Recent Advances in Drug Discovery and Cancer Diagnoses

Published:2020-09-18 Issue:21 Volume:20 Page:1855-1857
ISSN:1568-0266
Container-title:Current Topics in Medicinal Chemistry
language:en
Short-container-title:CTMC

Author:

Zhang Jian¹,Chai Haiting²

Affiliation:

1. School of Computer and Information Technology, Xinyang Normal University, Xinyang, China

2. College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Abstract

This editorial provides a brief overview of the thematic issue and the papers in it. The thematic issue is proposed to help chemists and biologists track the most recent advances in drug discovery and cancer diagnoses. The process of drug discovery involves the identification and validation of biological targets, the identification and optimization of lead compounds, preclinical development, and clinical trials. Cancer is a major public health problem in the world. The results of tissue diagnosis, blood tests, computed tomography scans, and cytogenetic analyses can provide informative clues about molecular changes and indicate proper prognoses. Timely detection of cancer significantly improves cancer outcomes by providing care at the earliest possible stage thus contributing greatly to the prevention and exacerbation and has become an important public health strategy in all settings. The collection of this thematic issue includes five articles. The first one reviews the current advances and limitations of deep learning in anticancer drug sensitivity prediction. The next review summarizes the most recent and high-quality research related to anticancer activities of Vitamin C. The third one reports the efficacy of two different sets of natural products (terpenoids and flavonoids) towards caspase-3 activity. The fourth one proposes a novel in silico method for predicting cancer biomarkers in human body fluids. The fifth article performs an in silico and in vitro investigation on isothymusin, which serves as a potential inhibitor of cancer cell proliferation.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference15 articles.

1. D'Agostino V.G.; Sighel D.; Zucal C.; Bonomo I.; Micaelli M.; Lolli G.; Provenzani A.; Quattrone A.; Adami V.; Screening approaches for targeting ribonucleoprotein complexes: a new dimension for drug discovery. SLAS Discovery : Advancing Life Sciences R 2019,24(3),314-331

2. Singh S.S.; Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 2006,7(2),165-182

3. Nayal M.; Honig B.; On the nature of cavities on protein surfaces: application to the identification of drug-binding sites. Proteins 2006,63(4),892-906

4. Vaquero-Garcia J.; Barrera A.; Gazzara M.R.; Gonzalez-Vallinas J.; Lahens N.F.; Hogenesch J.B.; Lynch K.W.; Barash Y.; A new view of transcriptome complexity and regulation through the lens of local splicing variations. eLife 2016,5

5. Shi L.; Campbell G.; Jones W.D.; Campagne F.; Wen Z.; Walker S.J.; Su Z.; Chu T.M.; Goodsaid F.M.; Pusztai L.; Shaughnessy J.D.; Oberthuer A.; Thomas R.S.; Paules R.S.; Fielden M.; Barlogie B.; Chen W.; Du P.; Fischer M.; Furlanello C.; Gallas B.D.; Ge X.; Megherbi D.B.; Symmans W.F.; Wang M.D.; Zhang J.; Bitter H.; Brors B.; Bushel P.R.; Bylesjo M.; Chen M.; Cheng J.; Cheng J.; Chou J.; Davison T.S.; Delorenzi M.; Deng Y.; Devanarayan V.; Dix D.J.; Dopazo J.; Dorff K.C.; Elloumi F.; Fan J.; Fan S.; Fan X.; Fang H.; Gonzaludo N.; Hess K.R.; Hong H.; Huan J.; Irizarry R.A.; Judson R.; Juraeva D.; Lababidi S.; Lambert C.G.; Li L.; Li Y.; Li Z.; Lin S.M.; Liu G.; Lobenhofer E.K.; Luo J.; Luo W.; McCall M.N.; Nikolsky Y.; Pennello G.A.; Perkins R.G.; Philip R.; Popovici V.; Price N.D.; Qian F.; Scherer A.; Shi T.; Shi W.; Sung J.; Thierry-Mieg D.; Thierry-Mieg J.; Thodima V.; Trygg J.; Vishnuvajjala L.; Wang S.J.; Wu J.; Wu Y.; Xie Q.; Yousef W.A.; Zhang L.; Zhang X.; Zhong S.; Zhou Y.; Zhu S.; Arasappan D.; Bao W.; Lucas A.B.; Berthold F.; Brennan R.J.; Buness A.; Catalano J.G.; Chang C.; Chen R.; Cheng Y.; Cui J.; Czika W.; Demichelis F.; Deng X.; Dosymbekov D.; Eils R.; Feng Y.; Fostel J.; Fulmer-Smentek S.; Fuscoe J.C.; Gatto L.; Ge W.; Goldstein D.R.; Guo L.; Halbert D.N.; Han J.; Harris S.C.; Hatzis C.; Herman D.; Huang J.; Jensen R.V.; Jiang R.; Johnson C.D.; Jurman G.; Kahlert Y.; Khuder S.A.; Kohl M.; Li J.; Li L.; Li M.; Li Q.Z.; Li S.; Li Z.; Liu J.; Liu Y.; Liu Z.; Meng L.; Madera M.; Martinez-Murillo F.; Medina I.; Meehan J.; Miclaus K.; Moffitt R.A.; Montaner D.; Mukherjee P.; Mulligan G.J.; Neville P.; Nikolskaya T.; Ning B.; Page G.P.; Parker J.; Parry R.M.; Peng X.; Peterson R.L.; Phan J.H.; Quanz B.; Ren Y.; Riccadonna S.; Roter A.H.; Samuelson F.W.; Schumacher M.M.; Shambaugh J.D.; Shi Q.; Shippy R.; Si S.; Smalter A.; Sotiriou C.; Soukup M.; Staedtler F.; Steiner G.; Stokes T.H.; Sun Q.; Tan P.Y.; Tang R.; Tezak Z.; Thorn B.; Tsyganova M.; Turpaz Y.; Vega S.C.; Visintainer R.; von Frese J.; Wang C.; Wang E.; Wang J.; Wang W.; Westermann F.; Willey J.C.; Woods M.; Wu S.; Xiao N.; Xu J.; Xu L.; Yang L.; Zeng X.; Zhang J.; Zhang L.; Zhang M.; Zhao C.; Puri R.K.; Scherf U.; Tong W.; Wolfinger R.D.; The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010,28(8),827-838

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Anticancer Activity of Novel Enmein-Type Diterpenoid Derivatives Targeting the PI3K/Akt/mTOR Signaling Pathway;Molecules;2024-08-27

2. Discovery of novel peptide–dehydroepiandrosterone hybrids inducing endoplasmic reticulum stress with effective in vitro and in vivo anti-melanoma activities;European Journal of Medicinal Chemistry;2024-04

3. Survey of In-silico Prediction of Anticancer Peptides;Current Topics in Medicinal Chemistry;2021-10-07

4. Anticancer potential of cardiac glycosides and steroid-azole hybrids;Steroids;2021-07